European Society of Medicine

ESMED small

Cardiovascular Disease Committee

Home  >  Global Health Center > Cardiovascular Disease Committee

Cardiovascular Disease Committee

We are committed to reducing the burden of cardiovascular disease through education, advocacy, and collaborative research.

What we want to achieve

Our Cardiovascular Disease Committee aims to significantly reduce the global impact of heart disease through strategic initiatives that span prevention, treatment, and policy reform. We seek to eliminate health disparities in cardiovascular outcomes by promoting equitable access to evidence-based care and resources. Through collaborative partnerships with healthcare providers, researchers, and policymakers, we work to advance innovative therapies, strengthen prevention programs, and establish comprehensive guidelines that improve patient outcomes. Our ultimate goal is to create a world where cardiovascular disease is preventable, treatable, and no longer a leading cause of mortality and morbidity.

Focus areas

Hypertension

Heart failure

Stroke

Arrhythmias

Cardiac devices

Committee members

Rino Frizzelli

Viadana Hospital Italy

Nilima Kundnani

Victor Babeș University of Medicine and Pharmacy Timișoara

Sameer Jamal

Hackensack Meridian School of Medicine

Arthur Siegel

McLean Hospital & Harvard Medical School

Latest publications

Theme Issue

Advances in Cardiac Electrophysiology and Device Innovation

The field of cardiac electrophysiology continues to evolve rapidly, driven by technological breakthroughs and innovative therapeutic approaches. This theme issue presents cutting-edge developments spanning from novel pacing strategies to artificial intelligence applications in device programming.

Review Article

The Stanford Legacy and the Future of Electrocardiographic Screening of Athletes

The purpose of this paper is to provide brief historical perspective, the experiences at our institution and our view of the future application of computerized Electrocardiography in screening for cardiovascular risk.

By Victor Froelicher et al. - Stanford University School of Medicine

Research Article

Cardiovascular Outcome in Type 2 Diabetes and Atrial Fibrillation - How to modify the increased cardiovascular risk?

The increased cardiovascular risk in patients with type 2 diabetes mellitus is further augmented by the presence of atrial fibrillation.

By Thomas Meinertz et al. - German Heart Foundation

Theme issues

Upcoming

Innovations in Arrhythmias

Challenges and Opportunities in Heart Failure

Advancements in Hypertension

Published

Researching cardiovascular disease?

We would like to hear from you. Write to us at [email protected]

Call for papers

Have a manuscript to publish in the society's journal?